Kidney Res Clin Pract.  2015 Mar;34(1):60-63. 10.1016/j.krcp.2014.09.004.

Idiopathic erythrocytosis in a patient on chronic hemodialysis

Affiliations
  • 1Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. eylee@sch.ac.kr

Abstract

A 78-year-old man on hemodialysis presented to our hospital with erythrocytosis. He had started hemodialysis 4 years previously, with a hemoglobin level of 9.8 g/dL, and was administered erythropoiesis stimulating agents and ferrous sulfate. Two years previously, his hemoglobin level increased to 14.5 g/dL and the treatment for anemia was discontinued. He continued hemodialysis thrice weekly; however, the hemoglobin level had increased to 17.0 g/dL at the time of presenting to our hospital. His serum erythropoietin level was 31.4 mIU/mL (range, 3.7-31.5 mIU/mL), carboxyhemoglobin level was 0.6% (range, 0-1.5%), and oxygen saturation in ambient air was 95.4%. The JAK2 V617F mutation was not observed and other bone marrow abnormalities were not identified. The patient was diagnosed with bladder cancer and a transurethral resection was performed. Eight months after the treatment of bladder cancer, his hemoglobin level was 15.1 g/dL, and he was diagnosed with idiopathic erythrocytosis.

Keyword

End-stage renal disease; Erythrocytosis; Hemodialysis

MeSH Terms

Aged
Anemia
Bone Marrow
Carboxyhemoglobin
Erythropoietin
Hematinics
Humans
Kidney Failure, Chronic
Oxygen
Polycythemia*
Renal Dialysis*
Urinary Bladder Neoplasms
Carboxyhemoglobin
Erythropoietin
Hematinics
Oxygen
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr